Cimpress plc is an online supplier of high-quality graphic design services and customized printed products. Its products cover business cards, brochures & websites, and e-commerce platforms, calendars, address labels, note pads & signage, etc. It has business in the U.S., Austria, China, Brazil, Australia, Canada, India, France, Japan, Italy, the U.K., Ireland, Mexico and the Netherlands. It has 4 segments. Vistaprint segment represents Vistaprint-branded websites focused on the N. America, Europe, Australia and New Zealand. Upload and Print segment comprises 2 subgroups: PrintBrothers & The Print Group. PrintBrothers includes the druck.at, Printdeal and WIRmachenDRUCK brands whereas PrintBrothers includes EasyFlyer, Exaprint, Pixartprinting and Tradeprint brands. National Pen segment includes the global operations of its Pen business. All Other comprises BuildASign (e-commerce provider), Printi (online printing solutions), VIDA (e-commerce provider) and YSD (end-to-end mass customization software solutions)....
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 21 February 2026
2019-10-01 11:33:00 Tuesday ET
The Trump administration postpones increasing 25% to 30% tariffs on $250 billion Chinese imports after China extends an olive branch to de-escalate Sino-Ame
2019-06-07 04:02:05 Friday ET
The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic
2017-03-21 09:37:00 Tuesday ET
Trump and Xi meet in the most important summit on earth this year. Trump has promised to retaliate against China's currency misalignment, steel trade
2018-12-22 14:38:00 Saturday ET
Federal Reserve raises the interest rate to the target range of 2.25% to 2.5% as of December 2018. Fed Chair Jerome Powell highlights the dovish interest ra
2024-05-05 10:31:00 Sunday ET
Stock Synopsis: Pharmaceutical post-pandemic patent development cycle In terms of stock market valuation, the major pharmaceutical sector remains at its
2017-06-09 06:37:00 Friday ET
To complement President Trump's pro-business economic policies such as low taxation, new infrastructure, greater job creation, and technological in
Statement
Ratio
News